{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:53:52Z","timestamp":1790268832388,"version":"4.1.0"},"reference-count":245,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The word dementia describes a class of heterogeneous diseases which etiopathogenetic mechanisms are not well understood. There are different types of dementia, among which, Alzheimer\u2019s disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD) are the more common. Currently approved pharmacological treatments for most forms of dementia seem to act only on symptoms without having profound disease-modifying effects. Thus, alternative strategies capable of preventing the progressive loss of specific neuronal populations are urgently required. In particular, the attention of researchers has been focused on phytochemical compounds that have shown antioxidative, anti-amyloidogenic, anti-inflammatory and anti-apoptotic properties and that could represent important resources in the discovery of drug candidates against dementia. In this review, we summarize the neuroprotective effects of the main phytochemicals belonging to the polyphenol, isothiocyanate, alkaloid and cannabinoid families in the prevention and treatment of the most common kinds of dementia. We believe that natural phytochemicals may represent a promising sources of alternative medicine, at least in association with therapies approved to date for dementia.<\/jats:p>","DOI":"10.3390\/molecules21040518","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T10:25:21Z","timestamp":1461234321000},"page":"518","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview"],"prefix":"10.3390","volume":"21","author":[{"given":"Rosaliana","family":"Libro","sequence":"first","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Giacoppo","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangavelu","family":"Soundara Rajan","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placido","family":"Bramanti","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-717X","authenticated-orcid":false,"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization \u201cWHO | Dementia\u201d. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs362\/en."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Raz, L., Knoefel, J., and Bhaskar, K. (2015). The neuropathology and cerebrovascular mechanisms of dementia. J. Cereb. Blood Flow Metab.","DOI":"10.1038\/jcbfm.2015.164"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.mpmed.2012.08.012","article-title":"Dementia","volume":"40","author":"Holmes","year":"2012","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Serrano-Pozo, A., Frosch, M.P., Masliah, E., and Hyman, B.T. (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med., 1.","DOI":"10.1101\/cshperspect.a006189"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Barage, S.H., and Sonawane, K.D. (2015). Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer\u2019s disease. Neuropeptides, 52.","DOI":"10.1016\/j.npep.2015.06.008"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40266-015-0273-x","article-title":"The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer\u2019s Disease","volume":"32","author":"Deardorff","year":"2015","journal-title":"Drugs Aging"},{"key":"ref_7","first-page":"228","article-title":"Alzheimer\u2019s disease: Early diagnosis and treatment","volume":"18","author":"Chu","year":"2012","journal-title":"Hong Kong Med. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jns.2014.09.021","article-title":"Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia","volume":"347","author":"Kwon","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"Thomas","year":"2015","journal-title":"Lancet"},{"key":"ref_11","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/exnr.1998.6868","article-title":"Mutation in the alpha-synuclein gene and sporadic Parkinson\u2019s disease, Alzheimer\u2019s disease, and dementia with Lewy bodies","volume":"153","author":"Higuchi","year":"1998","journal-title":"Exp. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mao, P. (2013). Oxidative Stress and Its Clinical Applications in Dementia. J. Neurodegener. Dis.","DOI":"10.1155\/2013\/319898"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.26428","article-title":"Combination therapies: The next logical Step for the treatment of synucleinopathies?","volume":"31","author":"Valera","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12031-011-9558-7","article-title":"Medical management of frontotemporal dementias: The importance of the caregiver in symptom assessment and guidance of treatment strategies","volume":"45","author":"Jicha","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40264-014-0161-z","article-title":"Cardiovascular effects of drugs used to treat Alzheimer\u2019s disease","volume":"37","author":"Howes","year":"2014","journal-title":"Drug Saf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/1060028015602274","article-title":"Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports from VigiBase","volume":"49","author":"Mouls","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/mnfr.200800182","article-title":"Vascular action of polyphenols","volume":"53","author":"Ghosh","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/nu2121231","article-title":"Chemistry and biochemistry of dietary polyphenols","volume":"2","author":"Tsao","year":"2010","journal-title":"Nutrients"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/jsfa.6473","article-title":"Effect of flavonoids on learning, memory and neurocognitive performance: Relevance and potential implications for Alzheimer\u2019s disease pathophysiology","volume":"94","author":"Vauzour","year":"2014","journal-title":"J. Sci. Food Agric."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.3390\/molecules15107313","article-title":"Plant phenolics: Extraction, analysis and their antioxidant and anticancer properties","volume":"15","author":"Dai","year":"2010","journal-title":"Molecules"},{"key":"ref_22","first-page":"924","article-title":"Anti-radiation and anti-oxidation properties of some polyphenols","volume":"35","author":"Baraboui","year":"1963","journal-title":"Ukr. Biokhim. Zhurnal"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jcb.22198","article-title":"The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells","volume":"107","author":"Hur","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1698S","DOI":"10.1093\/ajcn\/71.6.1698S","article-title":"Tea polyphenols: Prevention of cancer and optimizing health","volume":"71","author":"Mukhtar","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"292S","DOI":"10.1093\/ajcn\/81.1.292S","article-title":"Polyphenols and cardiovascular disease: Effects on endothelial and platelet function","volume":"81","author":"Vita","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Albarracin, S.L., Stab, B., Casas, Z., Sutachan, J.J., Samudio, I., Gonzalez, J., Gonzalo, L., Capani, F., Morales, L., and Barreto, G.E. (2012). Effects of natural antioxidants in neurodegenerative disease. Nutr. Neurosci., 15.","DOI":"10.1179\/1476830511Y.0000000028"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mnfr.201400290","article-title":"Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases","volume":"59","author":"Ngoungoure","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12263-008-0091-4","article-title":"The neuroprotective potential of flavonoids: A multiplicity of effects","volume":"3","author":"Vauzour","year":"2008","journal-title":"Genes Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: From ancient medicine to current clinical trials","volume":"65","author":"Hatcher","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archneur.57.6.824","article-title":"Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study","volume":"57","author":"Ganguli","year":"2000","journal-title":"Arch. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1471-4159.2009.06562.x","article-title":"Naturally occurring phytochemicals for the prevention of Alzheimer\u2019s disease","volume":"112","author":"Kim","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-0-387-46401-5_8","article-title":"Neuroprotective effects of curcumin","volume":"595","author":"Cole","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00709-015-0821-6","article-title":"Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin","volume":"253","author":"Waseem","year":"2016","journal-title":"Protoplasma"},{"key":"ref_34","first-page":"2093","article-title":"Chemical and structural features influencing the biological activity of curcumin","volume":"19","author":"Priyadarsini","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.2174\/09298673113209990210","article-title":"Neuroprotective properties of curcumin in Alzheimer\u2019s disease\u2014Merits and limitations","volume":"20","author":"Chin","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JAD-2004-6403","article-title":"Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models","volume":"6","author":"Baum","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1745-7254.2007.00651.x","article-title":"Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia","volume":"28","author":"Jin","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2015.03.045","article-title":"Curcumin inhibits A\u03b2-induced microglial inflammatory responses in vitro: Involvement of ERK1\/2 and p38 signaling pathways","volume":"594","author":"Shi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00210-010-0511-z","article-title":"Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia","volume":"381","author":"Rinwa","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPAR\u03b3 agonists as therapeutics for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.fct.2008.05.030","article-title":"Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation","volume":"46","author":"Park","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates \u03b2-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer\u2019s disease transgenic mouse model","volume":"33","author":"Durairajan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lu, X., Deng, Y., Yu, D., Cao, H., Wang, L., Liu, L., Yu, C., Zhang, Y., Guo, X., and Yu, G. (2014). Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer\u2019s disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103067"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2014.07.041","article-title":"Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP\/PS1 mice","volume":"36","author":"Yanagisawa","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejphar.2014.06.051","article-title":"Downregulation of PI3K\/Akt\/mTOR signaling pathway in curcumin-induced autophagy in APP\/PS1 double transgenic mice","volume":"740","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jnr.23322","article-title":"Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe\/PS1dE9 mice","volume":"92","author":"Wang","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","article-title":"Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model","volume":"102","author":"Borrelli","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/VHRM.S1839","article-title":"Vascular risk factors, cognitive decline, and dementia","volume":"4","author":"Duron","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1142\/S0192415X13500699","article-title":"Curcumin induces ABCA1 expression and apolipoprotein A-I-mediated cholesterol transmembrane in the chronic cerebral hypoperfusion aging rats","volume":"41","author":"Tian","year":"2013","journal-title":"Am. J. Chin. Med."},{"key":"ref_51","first-page":"821","article-title":"Hippocampal expression of synaptic structural proteins and phosphorylated cAMP response element-binding protein in a rat model of vascular dementia induced by chronic cerebral hypoperfusion","volume":"7","author":"Zhao","year":"2012","journal-title":"Neural Regen. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.09.004","article-title":"Resveratrol Reverses the Synaptic Plasticity Deficits in a Chronic Cerebral Hypoperfusion Rat Model","volume":"25","author":"Li","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ringman, J.M., Frautschy, S.A., Teng, E., Begum, A.N., Bardens, J., Beigi, M., Gylys, K.H., Badmaev, V., Heath, D.D., and Apostolova, L.G. (2012). Oral curcumin for Alzheimer\u2019s disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res. Ther., 4.","DOI":"10.1186\/alzrt146"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0974-8520.110524","article-title":"Effects of turmeric on Alzheimer\u2019s disease with behavioral and psychological symptoms of dementia","volume":"33","author":"Hishikawa","year":"2012","journal-title":"Ayu"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Brondino, N., Re, S., Boldrini, A., Cuccomarino, A., Lanati, N., Barale, F., and Politi, P. (2014). Curcumin as a Therapeutic Agent in Dementia: A Mini Systematic Review of Human Studies. Sci. World J., 2014.","DOI":"10.1155\/2014\/174282"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14737175.2015.1044981","article-title":"Clinical development of curcumin in neurodegenerative disease","volume":"15","author":"Hu","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/138161212798919075","article-title":"Resveratrol, a neuroprotective supplement for Alzheimer\u2019s disease","volume":"18","author":"Li","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(02)03543-6","article-title":"Resveratrol protects against global cerebral ischemic injury in gerbils","volume":"958","author":"Wang","year":"2002","journal-title":"Brain Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Rege, S.D., Geetha, T., Griffin, G.D., Broderick, T.L., and Babu, J.R. (2014). Neuroprotective effects of resveratrol in Alzheimer disease pathology. Front. Aging Neurosci., 6.","DOI":"10.3389\/fnagi.2014.00218"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11064-006-9255-z","article-title":"Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat","volume":"32","author":"Mokni","year":"2007","journal-title":"Neurochem. Res."},{"key":"ref_62","first-page":"1069","article-title":"Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells","volume":"17","author":"Kim","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0891-5849(03)00062-5","article-title":"Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death","volume":"34","author":"Jang","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bjp.0705688","article-title":"Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: Involvement of protein kinase C","volume":"141","author":"Han","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.mp.4001204","article-title":"Role of protein kinase Calpha in the regulated secretion of the amyloid precursor protein","volume":"8","author":"Racchi","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Cai, Z., Yan, L.-J., Li, K., Quazi, S.H., and Zhao, B. (2012). Roles of AMP-activated protein kinase in Alzheimer\u2019s disease. Neuromol. Med., 14.","DOI":"10.1007\/s12017-012-8173-2"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","article-title":"AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism","volume":"285","author":"Vingtdeux","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/YCO.0b013e32835112c1","article-title":"Sirtuins in cognitive ageing and Alzheimer\u2019s disease","volume":"25","author":"Braidy","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11357-012-9489-4","article-title":"Dietary resveratrol prevents Alzheimer\u2019s markers and increases life span in SAMP8","volume":"35","author":"Porquet","year":"2013","journal-title":"Age"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JAD-140444","article-title":"Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer\u2019s disease","volume":"42","author":"Porquet","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_71","first-page":"2050","article-title":"Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia","volume":"8","author":"Ma","year":"2013","journal-title":"Neural Regen. Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ozacmak, V.H., Sayan-Ozacmak, H., and Barut, F. (2015). Chronic treatment with resveratrol, a natural polyphenol found in grapes, alleviates oxidative stress and apoptotic cell death in ovariectomized female rats subjected to chronic cerebral hypoperfusion. Nutr. Neurosci.","DOI":"10.1179\/1476830515Y.0000000027"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3892\/etm.2014.1542","article-title":"Effects of resveratrol on apoptosis in a rat model of vascular dementia","volume":"7","author":"Sun","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","article-title":"Function and Regulation of CREB Family Transcription Factors in the Nervous System","volume":"35","author":"Lonze","year":"2002","journal-title":"Neuron"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Davinelli, S., Sapere, N., Zella, D., Bracale, R., Intrieri, M., and Scapagnini, G. (2012). Pleiotropic protective effects of phytochemicals in Alzheimer\u2019s disease. Oxid. Med. Cell. Longev., 2012.","DOI":"10.1155\/2012\/386527"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fct.2007.10.006","article-title":"Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG","volume":"46","author":"Na","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"ref_77","first-page":"16","article-title":"Epigallocatechin gallate attenuates amyloid \u03b2-induced inflammation and neurotoxicity in EOC 13.31 microglia","volume":"770","author":"Huang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jnutbio.2006.11.001","article-title":"Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells","volume":"18","author":"Kim","year":"2007","journal-title":"J. Nutr. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2011-101629","article-title":"Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer\u2019s amyloid-induced mitochondrial dysfunction","volume":"26","author":"Dragicevic","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2012.08.039","article-title":"Green tea (\u2212)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia","volume":"236","author":"Biasibetti","year":"2013","journal-title":"Behav. Brain Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3945\/jn.109.109785","article-title":"Green tea (\u2212)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice","volume":"139","author":"Lee","year":"2009","journal-title":"J. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s12035-013-8608-2","article-title":"(\u2212)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA\/p75NTR signaling in APP\/PS1 transgenic mice","volume":"49","author":"Liu","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.fct.2009.10.030","article-title":"Hepatotoxicity of high oral dose (\u2212)-epigallocatechin-3-gallate in mice","volume":"48","author":"Lambert","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","article-title":"Hepatotoxicity from green tea: A review of the literature and two unpublished cases","volume":"65","author":"Mazzanti","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0031-9422(00)00316-2","article-title":"The chemical diversity and distribution of glucosinolates and isothiocyanates among plants","volume":"56","author":"Fahey","year":"2001","journal-title":"Phytochemistry"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1207\/S15327914NC382_5","article-title":"Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli","volume":"38","author":"Conaway","year":"2000","journal-title":"Nutr. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.fct.2006.07.021","article-title":"Effect of storage, processing and cooking on glucosinolate content of Brassica vegetables","volume":"45","author":"Song","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.lungcan.2010.06.015","article-title":"Up-regulation of cytochrome P450 and phase II enzyme systems in rat precision-cut rat lung slices by the intact glucosinolates, glucoraphanin and glucoerucin","volume":"71","author":"Bagatta","year":"2011","journal-title":"Lung Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/carcin\/23.4.581","article-title":"Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane","volume":"23","author":"Fimognari","year":"2002","journal-title":"Carcinogenesis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11430","DOI":"10.1002\/anie.201402639","article-title":"Reactivity and stability of glucosinolates and their breakdown products in foods","volume":"53","author":"Hanschen","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmed.2012.04.003","article-title":"Glucosinolates and isothiocyanates in health and disease","volume":"18","author":"Kostov","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.3390\/molecules19066975","article-title":"Novel gram-scale production of enantiopure R-sulforaphane from Tuscan black kale seeds","volume":"19","author":"Rollin","year":"2014","journal-title":"Molecules"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1016\/j.phytochem.2008.09.008","article-title":"Determination of the absolute configuration of the glucosinolate methyl sulfoxide group reveals a stereospecific biosynthesis of the side chain","volume":"69","author":"Vergara","year":"2008","journal-title":"Phytochemistry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1872214809666150505164138","article-title":"The antioxidant properties of organosulfur compounds (sulforaphane)","volume":"9","author":"Binda","year":"2015","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fitote.2015.08.001","article-title":"An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases","volume":"106","author":"Giacoppo","year":"2015","journal-title":"Fitoterapia"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Tarozzi, A., Angeloni, C., Malaguti, M., Morroni, F., Hrelia, S., and Hrelia, P. (2013). Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid. Med. Cell. Longev., 2013.","DOI":"10.1155\/2013\/415078"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1089\/ars.2010.3731","article-title":"Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism","volume":"14","author":"Jazwa","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_98","first-page":"194","article-title":"The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis","volume":"18","author":"Giacoppo","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2013.07.2514","article-title":"RS-Glucoraphanin bioactivated with myrosinase treatment counteracts proinflammatory cascade and apoptosis associated to spinal cord injury in an experimental mouse model","volume":"334","author":"Galuppo","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/cns.12106","article-title":"Protective role of (RS)-glucoraphanin bioactivated with myrosinase in an experimental model of multiple sclerosis","volume":"19","author":"Giacoppo","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.bmc.2013.05.065","article-title":"Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson\u2019s disease","volume":"21","author":"Galuppo","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lee, C., Park, G.H., Lee, S.-R., and Jang, J.-H. (2013). Attenuation of \u03b2-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2. Oxid. Med. Cell. Longev., 2013.","DOI":"10.1155\/2013\/313510"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12272-009-1124-2","article-title":"Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome","volume":"32","author":"Park","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"35528","DOI":"10.1074\/jbc.M110.152686","article-title":"Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27","volume":"285","author":"Gan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","article-title":"Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases","volume":"29","author":"Sherman","year":"2001","journal-title":"Neuron"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.freeradbiomed.2007.05.029","article-title":"Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells","volume":"43","author":"Kwak","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-009-0116-5","article-title":"Sulforaphane suppresses LPS-induced inflammation in primary rat microglia","volume":"59","author":"Brandenburg","year":"2010","journal-title":"Inflamm. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"14396","DOI":"10.3390\/ijms150814396","article-title":"Neuroprotective effects of sulforaphane on cholinergic neurons in mice with Alzheimer\u2019s disease-like lesions","volume":"15","author":"Zhang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1533317514542645","article-title":"Sulforaphane ameliorates neurobehavioral deficits and protects the brain from amyloid \u03b2 deposits and peroxidation in mice with Alzheimer-like lesions","volume":"30","author":"Zhang","year":"2015","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phrs.2014.05.003","article-title":"Sulforaphane alleviates scopolamine-induced memory impairment in mice","volume":"85","author":"Lee","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Molchan, S.E., Martinez, R.A., Hill, J.L., Weingartner, H.J., Thompson, K., Vitiello, B., and Sunderland, T. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res. Brain Res. Rev., 17, 215\u2013226.","DOI":"10.1016\/0165-0173(92)90017-G"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Dwivedi, S., Rajasekar, N., Hanif, K., Nath, C., and Shukla, R. (2015). Sulforaphane Ameliorates Okadaic Acid-Induced Memory Impairment in Rats by Activating the Nrf2\/HO-1 Antioxidant Pathway. Mol. Neurobiol.","DOI":"10.1007\/s12035-015-9451-4"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12035-014-8699-4","article-title":"Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: A novel tool for Alzheimer\u2019s disease therapeutic application","volume":"50","author":"Kamat","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.7314\/APJCP.2014.15.20.8571","article-title":"Health benefits of Moringa oleifera","volume":"15","author":"Ibrahim","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1021\/jf0211480","article-title":"Profiling glucosinolates and phenolics in vegetative and reproductive tissues of the multi-purpose trees Moringa oleifera L. (horseradish tree) and Moringa stenopetala L.","volume":"51","author":"Bennett","year":"2003","journal-title":"J. Agric. Food Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.fitote.2014.03.018","article-title":"Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis","volume":"95","author":"Galuppo","year":"2014","journal-title":"Fitoterapia"},{"key":"ref_117","first-page":"343","article-title":"4(\u03b1-l-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that defends cerebral tissue and prevents severe damage induced by focal ischemia\/reperfusion","volume":"29","author":"Galuppo","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bmc.2014.11.022","article-title":"4(\u03b1-l-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury","volume":"23","author":"Giacoppo","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Sutalangka, C., Wattanathorn, J., Muchimapura, S., and Thukham-Mee, W. (2013). Moringa oleifera mitigates memory impairment and neurodegeneration in animal model of age-related dementia. Oxid. Med. Cell. Longev., 2013.","DOI":"10.1155\/2013\/695936"},{"key":"ref_120","first-page":"744","article-title":"Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer\u2019s disease & protection by Moringa oleifera","volume":"128","author":"Ganguly","year":"2008","journal-title":"Indian J. Med. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5214\/ans.0972.7531.2005.120301","article-title":"Effect of Moringa oleifera in Experimental Model of Alzheimer\u2019s Disease: Role of Antioxidants","volume":"12","author":"Ganguly","year":"2005","journal-title":"Ann. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jps.2600650230","article-title":"Isolation and chemistry of alkaloids from plants of the family Papaveraceae LXVII: Corydalis cava (L.) Sch. et K. (C. tuberosa DC)","volume":"65","author":"Preininger","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"ref_123","first-page":"155","article-title":"Exploiting plant alkaloids","volume":"37","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/138955711795049880","article-title":"Lead finding for acetyl cholinesterase inhibitors from natural origin: Structure activity relationship and scope","volume":"11","author":"Mukherjee","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/jphp.12090","article-title":"Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer\u2019s disease","volume":"65","author":"Konrath","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Mehta, M., Adem, A., and Sabbagh, M. (2012). New acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Int. J. Alzheimers. Dis., 2012.","DOI":"10.1155\/2012\/728983"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-1241.2009.02052.x","article-title":"Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer\u2019s disease: A review","volume":"63","author":"Kurz","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2000.2.2\/lschneider","article-title":"A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer\u2019s disease","volume":"2","author":"Schneider","year":"2000","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1586\/14737175.7.11.1457","article-title":"A rivastigmine patch for the treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease dementia","volume":"7","author":"Cummings","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Boot, B.P. (2015). Comprehensive treatment of dementia with Lewy bodies. Alzheimers. Res. Ther., 7.","DOI":"10.1186\/s13195-015-0128-z"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Birks, J.S., Chong, L.Y., and Grimley Evans, J. (2015). Rivastigmine for Alzheimer\u2019s disease. Cochrane Database Syst. Rev., 9.","DOI":"10.1002\/14651858.CD001191.pub4"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3233\/JAD-150518","article-title":"Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)","volume":"48","author":"Matsuzono","year":"2015","journal-title":"J. Alzheimers. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.clinthera.2015.05.510","article-title":"Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?","volume":"37","author":"Ehret","year":"2015","journal-title":"Clin. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/WAD.0b013e318260ab0a","article-title":"Rivastigmine patch ameliorates depression in mild AD: Preliminary evidence from a 6-month open-label observational study","volume":"27","author":"Spalletta","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_135","first-page":"167","article-title":"Effect of AChE and BuChE inhibition by rivastigmin in a group of old-old elderly patients with cerebrovascular impairment (SIVD type)","volume":"105","author":"Servello","year":"2014","journal-title":"Minerva Med."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Birks, J., McGuinness, B., and Craig, D. (2013). Rivastigmine for vascular cognitive impairment. Cochrane Database Syst. Rev., 5.","DOI":"10.1002\/14651858.CD004744.pub3"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2006\/315386","article-title":"Current and emerging pharmacological treatment options for dementia","volume":"17","author":"Ringman","year":"2006","journal-title":"Behav. Neurol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","article-title":"Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis","volume":"172","author":"Stinton","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jep.2004.02.012","article-title":"Galanthamine from snowdrop\u2014The development of a modern drug against Alzheimer\u2019s disease from local Caucasian knowledge","volume":"92","author":"Heinrich","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2014.04.037","article-title":"Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia","volume":"157","author":"Koola","year":"2014","journal-title":"Schizophr. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","article-title":"Efficacy and safety of galantamine in patients with mild to moderate Alzheimer\u2019s disease: Multicentre randomised controlled trial. Galantamine International-1 Study Group","volume":"321","author":"Wilcock","year":"2000","journal-title":"BMJ"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer\u2019s disease: An appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3233\/JAD-142148","article-title":"Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer\u2019s disease and mixed dementia: A one-year naturalistic study","volume":"45","author":"Miranda","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/ane.12195","article-title":"Galantamine treatment in outpatients with mild Alzheimer\u2019s disease","volume":"129","author":"Richarz","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s13760-015-0453-9","article-title":"Galantamine improves sleep quality in patients with dementia","volume":"115","author":"Naharci","year":"2015","journal-title":"Acta Neurol. Belg."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2009.01.024","article-title":"Galantamine inhibits beta-amyloid aggregation and cytotoxicity","volume":"280","author":"Matharu","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1460-9568.2009.06612.x","article-title":"Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons","volume":"29","author":"Melo","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.2174\/09298673113209990148","article-title":"Antioxidant activity of galantamine and some of its derivatives","volume":"20","author":"Tsvetkova","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuro.2007.11.004","article-title":"Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells","volume":"29","author":"Ezoulin","year":"2008","journal-title":"Neurotoxicology"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Birks, J., and Craig, D. (2013). Galantamine for vascular cognitive impairment. Cochrane Database Syst. Rev., 4.","DOI":"10.1002\/14651858.CD004746.pub2"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","article-title":"Galantamine treatment of vascular dementia: A randomized trial","volume":"69","author":"Auchus","year":"2007","journal-title":"Neurology"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000101512","article-title":"Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study","volume":"23","author":"Edwards","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0269881110387547","article-title":"Clinical practice with anti-dementia drugs: A revised (second) consensus statement from the British Association for Psychopharmacology","volume":"25","author":"Burns","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000113034","article-title":"Galantamine in frontotemporal dementia and primary progressive aphasia","volume":"25","author":"Kertesz","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000444253","article-title":"Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis","volume":"75","author":"Chen","year":"2016","journal-title":"Eur. Neurol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0885-3924(05)80006-5","article-title":"Cancer pain management according to WHO analgesic guidelines","volume":"5","author":"Schug","year":"1990","journal-title":"J. Pain Symptom Manag."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"16227","DOI":"10.1523\/JNEUROSCI.3915-11.2011","article-title":"Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70","volume":"31","author":"Cui","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cns.12316","article-title":"\u03bc-Opioid receptor attenuates A\u03b2 oligomers-induced neurotoxicity through mTOR signaling","volume":"21","author":"Wang","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","article-title":"Role of mTOR in physiology and pathology of the nervous system","volume":"1784","author":"Swiech","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"12977","DOI":"10.1523\/JNEUROSCI.4209-06.2006","article-title":"Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons","volume":"26","author":"Parsons","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jagp.2012.12.006","article-title":"The response of agitated behavior to pain management in persons with dementia","volume":"22","author":"Husebo","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Husebo, B.S., Ballard, C., Sandvik, R., Nilsen, O.B., and Aarsland, D. (2011). Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: Cluster randomised clinical trial. BMJ, 343.","DOI":"10.1136\/bmj.d4065"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuroscience.2013.07.021","article-title":"Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: A BOLD and perfusion MRI study","volume":"250","author":"Haller","year":"2013","journal-title":"Neuroscience"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/mds.25076","article-title":"Caffeine and risk of Parkinson\u2019s disease in a large cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","article-title":"Does caffeine intake protect from Alzheimer\u2019s disease?","volume":"9","author":"Maia","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","article-title":"The neuroprotective effects of caffeine: A prospective population study (the Three City Study)","volume":"69","author":"Ritchie","year":"2007","journal-title":"Neurology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-2012-111781","article-title":"High Blood caffeine levels in MCI linked to lack of progression to dementia","volume":"30","author":"Cao","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","article-title":"Beneficial effects of caffeine in a transgenic model of Alzheimer\u2019s disease-like tau pathology","volume":"35","author":"Laurent","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer\u2019s mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","article-title":"Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer\u2019s disease mice","volume":"17","author":"Arendash","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3892\/mmr.2013.1601","article-title":"Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1\/APP double transgenic mouse model of Alzheimer\u2019s disease","volume":"8","author":"Han","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","article-title":"Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease","volume":"15","author":"Nagahara","year":"2009","journal-title":"Nat. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2010.07.007","article-title":"Caffeine protects against oxidative stress and Alzheimer\u2019s disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet","volume":"49","author":"Prasanthi","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2009-0920","article-title":"Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study","volume":"16","author":"Eskelinen","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000371710","article-title":"Caffeine intake from coffee or tea and cognitive disorders: A meta-analysis of observational studies","volume":"44","author":"Kim","year":"2015","journal-title":"Neuroepidemiology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-2010-101428","article-title":"Coffee intake in midlife and risk of dementia and its neuropathologic correlates","volume":"23","author":"Gelber","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/neu.10102","article-title":"Nicotinic receptors in aging and dementia","volume":"53","author":"Picciotto","year":"2002","journal-title":"J. Neurobiol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Echeverria, V., Yarkov, A., and Aliev, G. (2016). Positive modulators of the \u03b17 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer\u2019s disease. Prog. Neurobiol.","DOI":"10.1016\/j.pneurobio.2016.01.002"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.410420205","article-title":"Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity","volume":"42","author":"Kihara","year":"1997","journal-title":"Ann. Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0006-3223(02)01417-8","article-title":"Nicotine breaks down preformed Alzheimer\u2019s beta-amyloid fibrils in vitro","volume":"52","author":"Ono","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/pr.108.000562","article-title":"Nicotinic acetylcholine receptor signalling: Roles in Alzheimer\u2019s disease and amyloid neuroprotection","volume":"61","author":"Buckingham","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/bi035728h","article-title":"Both the d-(+) and l-(\u2212) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity","volume":"43","author":"Moore","year":"2004","journal-title":"Biochemistry"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neurobiolaging.2009.04.015","article-title":"Chronic nicotine restores normal A\u03b2 levels and prevents short-term memory and E-LTP impairment in A\u03b2 rat model of Alzheimer\u2019s disease","volume":"32","author":"Srivareerat","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s11064-008-9629-5","article-title":"Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice","volume":"33","author":"Shim","year":"2008","journal-title":"Neurochem. Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.neuroscience.2004.10.006","article-title":"V Repeated nicotine exposure in rats: Effects on memory function, cholinergic markers and nerve growth factor","volume":"130","author":"Hernandez","year":"2005","journal-title":"Neuroscience"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1073\/pnas.0408500102","article-title":"Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer\u2019s disease","volume":"102","author":"Oddo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2010.03.029","article-title":"Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats","volume":"637","author":"Deng","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.expneurol.2007.03.002","article-title":"Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases","volume":"205","author":"Ono","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-003-1614-8","article-title":"Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment","volume":"171","author":"White","year":"2004","journal-title":"Psychopharmacology"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.0b013e31823efcbb","article-title":"Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial","volume":"78","author":"Newhouse","year":"2012","journal-title":"Neurology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","article-title":"Huperzine A from Huperzia species\u2014An ethnopharmacolgical review","volume":"113","author":"Ma","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Xing, S.-H., Zhu, C.-X., Zhang, R., and An, L. (2014). Huperzine a in the treatment of Alzheimer\u2019s disease and vascular dementia: A meta-analysis. Evid. Based Complement. Altern. Med., 2014.","DOI":"10.1155\/2014\/363985"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2005.06.026","article-title":"Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production","volume":"519","author":"Tang","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(00)01088-0","article-title":"Protective effects of huperzine A on beta-amyloid(25-35) induced oxidative injury in rat pheochromocytoma cells","volume":"286","author":"Xiao","year":"2000","journal-title":"Neurosci. Lett."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/jnr.20791","article-title":"Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism","volume":"83","author":"Gao","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jnr.10075","article-title":"Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation","volume":"67","author":"Xiao","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Wang, R., Yan, H., and Tang, X. (2006). Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin., 27.","DOI":"10.1111\/j.1745-7254.2006.00255.x"},{"key":"ref_200","first-page":"27","article-title":"Anticholinesterase effects of huperzine A, E2020, and tacrine in rats","volume":"19","author":"Wang","year":"1998","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2013.02.026","article-title":"Huperzine A promotes hippocampal neurogenesis in vitro and in vivo","volume":"1506","author":"Ma","year":"2013","journal-title":"Brain Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(01)01030-5","article-title":"Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat","volume":"421","author":"Wang","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2004.01.055","article-title":"Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1-40) infused rats and human embryonic kidney 293 Swedish mutant cells","volume":"360","author":"Zhang","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Yang, G., Wang, Y., Tian, J., and Liu, J.-P. (2013). Huperzine A for Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized clinical trials. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074916"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12013-011-9258-5","article-title":"Treatment with Huperzine A improves cognition in vascular dementia patients","volume":"62","author":"Xu","year":"2012","journal-title":"Cell Biochem. Biophys."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Hao, Z., Liu, M., Liu, Z., and Lv, D. (2009). Huperzine A for vascular dementia. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD007365.pub2"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.bmc.2004.06.035","article-title":"Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects","volume":"12","author":"Stefek","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0024-3205(02)02200-2","article-title":"A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species","volume":"72","year":"2002","journal-title":"Life Sci."},{"key":"ref_209","first-page":"548","article-title":"In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines","volume":"59","author":"Kettmann","year":"2004","journal-title":"Pharmazie"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0378-8741(03)00045-X","article-title":"In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine","volume":"86","author":"Tran","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"RA164","DOI":"10.12659\/MSM.881842","article-title":"Modulating gut microbiota as an anti-diabetic mechanism of berberine","volume":"17","author":"Han","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"ref_212","first-page":"73","article-title":"Anti-blastic properties of berberine and its derivatives","volume":"35","author":"Shvarev","year":"1972","journal-title":"Farmakol. Toksikol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.lfs.2005.02.033","article-title":"Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract","volume":"77","author":"Wang","year":"2005","journal-title":"Life Sci."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ptr.2968","article-title":"Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders","volume":"24","author":"Kulkarni","year":"2010","journal-title":"Phytother. Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1016\/j.bmc.2013.07.011","article-title":"Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and A\u03b2 aggregation and antioxidant activity","volume":"21","author":"Su","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2174\/1568026615666150827095433","article-title":"The Role of Berberine in the Multi-Target Treatment of Senile Dementia","volume":"16","author":"Huang","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1055\/s-0034-1383038","article-title":"Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer\u2019s disease","volume":"80","author":"Kim","year":"2014","journal-title":"Planta Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2006.11.043","article-title":"Berberine alters the processing of Alzheimer\u2019s amyloid precursor protein to decrease Abeta secretion","volume":"352","author":"Asai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Zhu, F., Wu, F., Ma, Y., Liu, G., Li, Z., Sun, Y., and Pei, Z. (2011). Decrease in the production of \u03b2-amyloid by berberine inhibition of the expression of \u03b2-secretase in HEK293 cells. BMC Neurosci., 12.","DOI":"10.1186\/1471-2202-12-125"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2011.10.019","article-title":"Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase\/AKT and NF-E2-related factor-2 signaling pathway in astrocytes","volume":"12","author":"Chen","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.2042-7158.2012.01529.x","article-title":"Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways","volume":"64","author":"Jia","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2010.09.038","article-title":"Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson\u2019s disease","volume":"486","author":"Kwon","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Yan, H.-M., Xia, M.-F., Wang, Y., Chang, X.-X., Yao, X.-Z., Rao, S.-X., Zeng, M.-S., Tu, Y.-F., Feng, R., and Jia, W.-P. (2015). Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134172"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ptr.5475","article-title":"A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome","volume":"29","author":"Chen","year":"2015","journal-title":"Phytother. Res."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"18781","DOI":"10.3390\/molecules191118781","article-title":"Cannabinoids: New promising agents in the treatment of neurological diseases","volume":"19","author":"Giacoppo","year":"2014","journal-title":"Molecules"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J. Mol. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neulet.2006.06.012","article-title":"CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons","volume":"404","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","article-title":"Neuroprotective antioxidants from marijuana","volume":"899","author":"Hampson","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Esposito, G., Scuderi, C., Valenza, M., Togna, G.I., Latina, V., de Filippis, D., Cipriano, M., Carrat\u00f9, M.R., Iuvone, T., and Steardo, L. (2011). Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028668"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer\u2019s disease","volume":"79","author":"Reigada","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1191\/1352458504ms1048oa","article-title":"Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled, crossover study","volume":"10","author":"Vaney","year":"2004","journal-title":"Mult. Scler."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Iring, A., Ruisanchez, \u00c9., Leszl-Ishiguro, M., Horv\u00e1th, B., Benk\u0151, R., Lacza, Z., J\u00e1rai, Z., S\u00e1ndor, P., di Marzo, V., and Pacher, P. (2013). Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053390"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01112-8","article-title":"Hemodynamic effects of cannabinoids: Coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors","volume":"423","author":"Wagner","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3390\/ph3082689","article-title":"Cannabinoids and Dementia: A Review of Clinical and Preclinical Data","volume":"3","author":"Walther","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00213-006-0343-1","article-title":"Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia","volume":"185","author":"Walther","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease","volume":"12","author":"Volicer","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Krishnan, S., Cairns, R., and Howard, R. (2009). Cannabinoids for the treatment of dementia. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD007204.pub2"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/4\/518\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:22:39Z","timestamp":1760210559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/4\/518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":245,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4]]}},"alternative-id":["molecules21040518"],"URL":"https:\/\/doi.org\/10.3390\/molecules21040518","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}